COVID-19 Cases on the Rise Again

Tell us how we can help.

Bring BASE10’s kits to your pharmacy.

Your Health Starts Here

Thank you for sending us a message!

For immediate concerns, you may reach our customer and sales support at +1 (866) 710 1018 or email us at +1 (866) 710 1018 +1 (866) 710 1018 Patient Portal Pharmacists Login LTC Administrators/Providers More on Clinical Decision Algorithms Medical/Healthcare Facilities Corporate Pharmacies More on Genomics Corporate Pharmacy Long-Term Care Facilities About Us PlexusDX Resources News and Articles Careers Events Medical/Healthcare Facilities Corporate Pharmacies More on Clinical Decision Algorithms Corporate Pharmacy Long-Term Care Facilities More on Genomics About Us PlexusDX Resources News and Articles Careers Events Contact Us Contact Us

According to HHS data compiled by the New York Times, nationwide COVID-19 cases have increased 50% over the last two weeks in 47 states, just as the country’s death toll surpasses 1,000,000 people. Meanwhile, hospitalizations due to COVID-19 have gone up 18% across the country, with 40 states identifying an increase.

Even so, the use of rapid, at-home COVID-19 tests suggests that HHS data is undercounting cases due to them not being reported. In addition, there’s been widespread underreporting as a result of more patients having milder cases due to vaccinations and prior infections.

As of this week, an average of 17,532 people are hospitalized daily with COVID-19. According to the CDC, 68.1% of new cases in the U.S. are a result of the omicron subvariant BA.2, which is the more contagious strain of the virus.

A report using data from the Centers for Disease Control and Prevention (CDC) found that as of February 2022 there was a high infection rate for the Omicron variant, especially among children.

The report shows that close to 75% of children and adolescents have had serologic evidence of previous SARS-CoV-2 infection, implying that the greatest increases in seroprevalence occurred in the age groups with the lowest vaccination coverage.

The Morbidity and Mortality Weekly Report (MMWR) examined U.S. trends in infection-induced SARS-CoV-2 seroprevalence during September 2021–February 2022 by age group, taking into account that the usual methods of disease surveillance don’t recognize all COVID-19 cases because some are asymptomatic, while others aren’t diagnosed or reported.

COVID-19 and various other infections can wreak havoc in nursing homes due to the large number of residents and their fragile immune systems. Early on, BASE10 advocated for providers to have access to automated, clinical support systems that can adapt to COVID-19’s peaks and valleys.

Utilizing a 5-layered approach, BASE10 has been at the forefront of managing and steering long-term care facilities toward building an innovative and cost-effective infection management program, incorporating intuitive population health management with individual risk factors and resident care coordination.

Staffing shortages and outdated processes mixed with rising infection rates have challenged the healthcare system to adapt and find new methodologies. BASE10 offers a solution that can be applied to multiple facilities, including big chains, enabling them to manage not only COVID-19 but a plethora of other infectious diseases that can run rampant among the elderly.

Sources: Centers for Disease Control and Prevention Centers for Disease Control and Prevention Becker’s Hospital Review Becker’s Hospital Review Covid-19 Death Tole Covid-19 Death Tole

About BASE10
Located in Chicago, BASE10 is a healthcare software technology company whose platform creates turnkey disease management programs that can be deployed at scale for nursing home operators, pharmacies, payors, and self-funded employers. 



Other articles you might like

Similar Posts

Leave a Reply